FIELD: pharmaceutical industry.
SUBSTANCE: claimed adsorbent contains spherical active carbon, obtained from thermosetting resin as carbon source, having particle size of 0.001-1 mm, specific surface determined by Langmuir adsorption equation of 1000 m2/g or more and pore volume of 7.5-15000 nm in diameter less than 0.25 ml/g. Also disclosed is adsorbent being similar to abovementioned one, wherein total content of acidic groups is 0.40-1.00 meq/g; total content of basic groups is 0.4-1.1 meq/g. Pharmaceutical compositions contain said adsorbents and pharmaceutically acceptable carriers and recipients. Agents of present invention are useful in treatment of kidney or liver diseases or disorders associated with uremic substance by administration of said adsorbents.
EFFECT: products of increased selectivity.
21 cl, 5 ex, 2 tbl, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ADSORBENT FOR PERORAL ADMINISTRATION | 2003 |
|
RU2306941C2 |
| ORALLY ADMINISTRATED ADSORBENT, THERAPEUTIC AGENT FOR KIDNEY DISEASE AND THERAPEUTIC AGENT FOR LIVER DISEASE | 2014 |
|
RU2632432C2 |
| ORAL ADSORBENT AND AGENT FOR TREATMENT OR PREVENTION OF RENAL OR HEPATIC DISEASE | 2005 |
|
RU2396965C2 |
| ORAL ADSORBENT AND AGENT FOR TREATMENT OR PREVENTION OF RENAL OR HEPATIC DISEASE | 2005 |
|
RU2396964C2 |
| METHOD OF PRODUCING SPHERICAL ACTIVATED CARBON | 2005 |
|
RU2375302C2 |
| MEDICAL ADSORBENT AND METHOD FOR ITS OBTAINING | 2011 |
|
RU2627464C2 |
| METHOD OF PRODUCING ADSORBENT BASED ON ACTIVATED CARBON | 2020 |
|
RU2811471C2 |
| AGENT FOR ELIMINATION OF CIRCULAR DYSFUNCTION FACTOR | 2005 |
|
RU2362570C2 |
| ADSORBENTS FOR ORAL ADMINISTRATION | 2012 |
|
RU2583934C2 |
| FORMULATIONS FOR ORAL DELIVERY OF ADSORBENTS IN INTESTINE | 2016 |
|
RU2681315C2 |
